Canara HSBC Life Insurance raises Rs 750 crore from anchor investors ahead of IPO

NEW DELHI: Canara HSBC Life Insurance Company Limited has successfully mobilised Rs 750.32 crore from 33 anchor investors, setting the stage for its upcoming initial public offering (IPO). The company allotted 7.07 crore equity shares to these investors at the upper end of its price band, Rs 106 per share.

The IPO’s price band has been fixed at Rs 100 to Rs 106 per equity share of a face value of Rs 10. The public offer will open for subscription on Friday, October 10, 2025, and close on Tuesday, October 14, 2025. According to the company’s filing, retail investors can bid for a minimum of 140 equity shares and in multiples thereof.

The anchor investor book saw strong participation from prominent domestic and foreign institutions. Leading the pack were funds from ICICI Prudential Mutual Fund and HDFC Mutual Fund. ICICI Prudential’s Banking and Financial Services Fund and Innovation Fund were the largest investors from the group, each allocated shares worth Rs 488 crore, constituting 6.50 percent of the total anchor portion.

Other significant subscribers included Mirae Asset ELSS Tax Saver Fund (5.94%), HDFC Trustee Company Ltd. for its Balanced Advantage Fund (7.47%), and a suite of funds from WhiteOak Capital.

A substantial 60.31 percent of the total anchor shares, amounting to 4.26 crore equity shares worth Rs 452.55 crore, were allotted to domestic mutual funds. These investments came through 18 different schemes from eight asset management companies, underscoring strong domestic institutional confidence in the insurance provider.

The list of book running lead managers (BRLMs) for the offer includes SBI Capital Markets Limited, BNP Paribas, HSBC Securities and Capital Markets (India) Private Limited, JM Financial Limited, and Motilal Oswal Investment Advisors Limited.

The successful closure of the anchor book is a key precursor to the public issue, often seen as an indicator of institutional appetite for the offering. The funds raised will contribute to the company’s capital base as it moves forward with its listing plans.

Latest

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Cohance Lifesciences hits 20% upper circuit: Why the stock rising today?

Cohance Lifesciences jumped 20% after appointing former Cipla CEO Umang Vohra. Investors are betting his leadership can accelerate growth and transform the comp

Decoding the Sun Pharma $11.75 billion deal: Why the pharma stock jumped 7% today?

The stock was trading around Rs 1,739.70 as of 9:46 am, up over 7%, after touching a high of Rs 1,741.85 during the session, reflecting strong investor interest

Topics

AI era hiring: Rs 50,000 stipend, flexible roles, and real work from day 1

Newton School of Technology's latest placement cycle expanded from 10 roles to 11 as companies assessed candidates in real time. The shift highlighted growing d

Is NPS Swasthya enough for medical emergencies? Here’s the reality

With rising healthcare costs, many are turning to NPS Swasthya as a safety net. But is it enough when a real emergency strikes? The answer may not be as reassur

Cursor AI Agent wipes out startup database in 9 seconds, founder shares 30-hour chaos timeline

A startup founder said Cursor AI Agent erased the company database in nine seconds. The account traced 30 hours of disruption after the incident.

Explained: Why stock markets are rising even as crude oil remains above $100

Benchmark indices rallied in early trade on Monday despite crude oil remaining elevated above $100. The move reflected bargain buying and global AI-led optimism

Reopen the Strait of Hormuz and end the war, Iran offers new proposal to US

Iran has reportedly offered a two-stage plan to US via intermediary Pakistan, which offers prolonged period of ceasefire extension or a permanent end to the war

Sun Pharma’s biggest-ever bet: Why markets cheered the Organon mega deal

Sun Pharma just made the biggest bet in Indian pharma history. Markets loved it instantly. Here’s why investors backed the Organon deal despite the massive pr

Watch out Apple and Samsung, OpenAI is making AI smartphone with agentic capabilities

OpenAI is reportedly working with MediaTek and Qualcomm on smartphone processors, aiming to build an AI-first device powered by agent-led experiences.

ICSE, ISC board results to be out this week? Here’s what CISCE official has to say

The Council for the Indian School Certificate Examinations (CISCE) will declare the much-awaited ICSE Class 10 and ISC Class 12 Results 2026 shortly. Officials
spot_img

Related Articles

Popular Categories

spot_imgspot_img